Thomas Asmar

Thomas counsels companies in a variety of industries on the design and implementation of compensation arrangements, including employment agreements, equity compensation plans, incentive compensation, deferred compensation, severance agreements and change-in-control arrangements.

Thomas advises clients on tax, securities and corporate governance law issues as they relate to executive compensation and employee benefit arrangements. He also counsels clients on golden parachute payments, the limits on the deductibility of executive compensation, the tax rules regarding nonqualified deferred compensation, executive compensation disclosure and reporting for proxy statements and other securities filings, and pension and welfare plan matters.

He writes and speaks frequently on legal developments of importance to his clients, including topics impacting corporate officers and directors.

• Abbott Laboratories in its USD 890 million acquisition of Cardiovascular Systems

• Affirm in its acquisition of Returnly

• Bandcamp in its sale to Epic Games

• Bayer AG in its acquisition of Asklepios BioPharmaceutical for up to USD 4.0 billion

• Bayer AG in its acquisition of Vividion Therapeutics for up to USD 2.0 billion

• Instacart in its acquisition of SBOT Technologies

• Huttig Building Products in its sale to Woodgrain

• LiveRamp in its acquisition of DataFleets

• Mozilla in its acquisition of Fakespot

• Mytheresa Group in its separation from The Neiman Marcus Group and subsequent IPO valued at USD 2.2 billion.

• Pronto Money Transfer in its sale to Banco Inter

• Shanghai Jin Jiang International Hotels in the sale of Radisson Hospitality to Choice Hotels

• Snowflake on its acquisitions of Streamlit and Applica

• National Association of Stock Plan Professionals (NASPP)
• Global Equity Organization (GEO)